PG

Business Context and Reporting Period

Company: The Procter & Gamble Company (P&G)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended March 31, 2025
Business Overview: P&G is a global leader in fast-moving consumer goods, operating across five reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The company sells products in approximately 180 countries.

Key Financial Metrics

Note: Total Debt calculated as Debt due within one year ($9,889) plus Long-term debt ($24,252) as of March 31, 2025.

Material Changes vs. Prior Period

• Revenue: Net sales decreased 2% in Q3 2025 and were flat for the nine-month period compared to the prior year. The decline was driven by unfavorable foreign exchange impacts (approx. 2%) and volume declines, partially offset by higher pricing (approx. 1%).
• Profitability: Operating income increased 2% in Q3 and 10% for the nine-month period. The nine-month increase was significantly aided by a $1.3 billion non-cash impairment charge on the Gillette intangible asset recorded in the prior year (Q3 2024), which is not present in the current period.
• Net Earnings: Net earnings were flat in Q3 but increased 5% for the nine-month period. This growth is largely attributable to the absence of the prior year's impairment charge, partially offset by current year restructuring charges related to the liquidation of operations in Argentina.
• Segment Performance:
  • Health Care: Organic sales increased low single digits; net earnings grew 8% (Q3) and 7% (9M).
  • Beauty: Net sales declined 2% (Q3) and 2% (9M) due to unfavorable mix (specifically SK-II) and foreign exchange. Net earnings declined 8% (Q3) and 11% (9M).
  • Grooming: Net sales were flat for the nine-month period; net earnings increased 4% (9M).
  • Fabric & Home Care: Net sales were flat for the nine-month period; net earnings increased 1% (9M).
  • Baby, Feminine & Family Care: Net sales declined 4% (Q3) and 1% (9M); net earnings declined 12% (Q3) and 3% (9M).

Guidance, Outlook, and Risks

• Restructuring: The company completed a limited market portfolio restructuring in Q2 2025, involving the substantial liquidation of operations in Argentina. This resulted in approximately $0.8 billion in after-tax incremental charges, primarily non-cash foreign currency translation losses. Ongoing restructuring costs are expected to range from $250 million to $500 million annually.
• Capital Allocation: P&G reaffirmed its expectation to repurchase $6 billion to $7 billion of shares in fiscal year 2025. In Q3 2025, the company repurchased approximately 8 million shares for $1.35 billion.
• Non-GAAP Measures: Core EPS (excluding restructuring and impairment items) increased 3% to $5.35 for the nine months ended March 31, 2025. Organic sales growth was 2% for the nine-month period.
• Risks and Contingencies:
  • Foreign Exchange: Significant exposure to currency fluctuations, particularly the weakening of foreign currencies against the U.S. dollar, negatively impacting sales and earnings.
  • Commodities: Exposure to volatile input costs, including oil-derived resins and paper-based materials.
  • Geopolitical: Risks related to the war in Russia and Ukraine, though the Russia business represents less than 2% of consolidated net sales.
  • Intangible Assets: The Gillette indefinite-lived intangible asset ($12.8 billion carrying value) remains sensitive to changes in discount rates, growth rates, and currency devaluation, which could trigger future impairment charges.

Investor Verification Checklist

• Organic Growth vs. Reported Sales: Verify the divergence between flat reported sales and 2% organic sales growth to understand the magnitude of foreign exchange headwinds.
• Restructuring Impact: Confirm the one-time nature of the Argentina liquidation charges ($0.8 billion after-tax) and their exclusion from Core EPS.
• Gillette Asset Valuation: Review the sensitivity analysis for the Gillette intangible asset, noting that a 25 basis-point increase in the discount rate could reduce its estimated fair value by 5%.
• Segment Mix: Investigate the specific drivers of the decline in the Beauty segment, particularly the performance of the SK-II brand and its impact on overall margin.
• Cash Flow Productivity: Assess the 80% adjusted free cash flow productivity ratio to evaluate capital efficiency relative to net earnings.